John Wagstaff, MD, professor at Swansea University Medical School, discusses the survival benefit of immunotherapy for patients with bladder cancer.
John Wagstaff, MD
Advertisement
Articles by John Wagstaff, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Vorasidenib Elicits Early Metabolic Responses in IDH-Mutant Glioma
2
Cross Currents: New Frontiers in ADC Therapy for Breast Cancer
3
Mirdametinib Deepens Responses in NF1-Associated Plexiform Neurofibroma
4
Dr Forde on Selecting Neoadjuvant and Perioperative Immunotherapy in Resectable NSCLC
5